| Literature DB >> 28429612 |
Yoshinori Watanabe1, Yoko Hirano2, Yuko Asami2, Maki Okada3, Kazuya Fujita3.
Abstract
A unique database named 'AN-SAPO' was developed by Iwato Corp. and Japan Brain Corp. in collaboration with the psychiatric clinics run by Himorogi Group in Japan. The AN-SAPO database includes patients' depression/anxiety score data from a mobile app named AN-SAPO and medical records from medical prescription software named 'ORCA'. On the mobile app, depression/anxiety severity can be evaluated by answering 20 brief questions and the scores are transferred to the AN-SAPO database together with the patients' medical records on ORCA. Currently, this database is used at the Himorogi Group's psychiatric clinics and has over 2000 patients' records accumulated since November 2013. Since the database covers patients' demographic data, prescribed drugs, and the efficacy and safety information, it could be a useful supporting tool for decision-making in clinical practice. We expect it to be utilised in wider areas of medical fields and for future pharmacovigilance and pharmacoepidemiological studies.Entities:
Keywords: Patient-reported outcome; app; database; pharmacovigilance; post-marketing surveillance
Mesh:
Year: 2017 PMID: 28429612 DOI: 10.1080/13651501.2017.1315139
Source DB: PubMed Journal: Int J Psychiatry Clin Pract ISSN: 1365-1501 Impact factor: 1.812